The Morning Brief Indo-US Trade Deal: Strategy or Surrender?
9 snips
Feb 6, 2026 Edward Alden, a U.S. trade policy expert, and Abhijit Das, an international trade and WTO negotiator, unpack a sudden U.S.-India trade announcement. They discuss the deal’s structural imbalance, risks to Indian agriculture and generics, digital trade and WTO implications, enforcement gaps, and the constitutional and political limits of U.S. emergency tariff powers.
AI Snips
Chapters
Transcript
Episode notes
Tariff Cut Creates Structural Imbalance
- The US would cut reciprocal tariffs to 18% while India would eliminate tariffs on many US products.
- That structural imbalance tilts the arrangement heavily in Washington's favor.
Pair Quotas With Minimum Import Prices
- If India allows limited low-tariff agricultural access, pair it with a minimum import price to prevent dumping.
- Use tariff-rate quotas plus floor prices to shield domestic farmers from subsidized US supplies.
Pharma Rules Threaten Generics
- US may push changes to India's patent law (Section 3D) and seek data exclusivity, threatening generics.
- Those changes would erode India's generic drug industry and limit affordable medicine access.